Yahoo Italia Ricerca nel Web

Entra

Risultati di ricerca

  1. ir.tevapharm.com › news-and-events › press-releasesTeva Pharmaceutical Industries Ltd. - Teva and Medincell Announce...

    8 mag 2024 · The study met its primary endpoint achieving clinically meaningful and statistically significant reductions across all TEV-‘749 dose groups versus placebo in the Positive and Negative Syndrome Scale (PANSS) total score, a widely used assessment tool for schizophrenia symptom severity

  2. www.psychiatrictimes.com › view › phase-3-solaris-trialPhase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in...

    9 mag 2024 · Teva and Medincell announce positive phase 3 efficacy results from SOLARIS trial evaluating TEV-‘749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia.

  3. Immagini

    • Rangers notch third straight win in First Citizens Cup
    • SAP and Grenades to clash in Joma’s $50,000 knockout football final ...
    • Saint Lucia First Division – The 94th Minute
    • UNITED - CHAMPIONS UP NORTH - St. Lucia News From The Voice
    • Development of accelerators from E.O. Lawrence's first 80 keV ...

    Mostra tutto

  4. www.tevapharm.com › news-and-media › latest-newsTeva and Medincell Announce Positive Phase 3 Efficacy Results...

    8 mag 2024 · Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia. May 08, 2024. The study met its primary endpoint achieving clinically meaningful and statistically significant reductions across all ...

  5. www.aifa.gov.it › - › chiarimenti-in-merito-alle-determinazionChiarimenti in merito alle Determinazioni per i nuovi...

    3 giorni fa · Con riferimento alle recenti Determinazioni AIFA, relative alla revisione delle condizioni negoziali delle specialità medicinali afferenti alla classe dei Nuovi Anticoagulanti Orali (NAO) - Pradaxa, Eliquis, Lixiana e Xarelto - si chiarisce che, ai fini della rimborsabilità dei suddetti farmaci per le indicazioni FANV e TVP/EP, è confermata la modalità di prescrizione attraverso PT web.

  6. www.fadoi.org › eventi › appropriatezza-terapeutica-e-gestioneAppropriatezza terapeutica e gestione del TEV - FADOI

    11 mag 2024 · Il corso, destinato ai MMG, affronta le tematiche cliniche e burocratiche, nonché quelle legate all’autonomia e responsabilità del Medico di Medicina Generale, nella gestione del TEV. A tale scopo verranno fornite le competenze, le istruzioni e tutto quanto necessario per la gestione clinica e farmacologica, anche preventiva, del ...

  7. www.empr.com › home › newsLong-Acting Subcutaneous Olanzapine Effective in Schizophrenia...

    8 mag 2024 · Teva and Medincell announce positive phase 3 efficacy results from SOLARIS trial evaluating TEV-‘749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with...

  8. www.drugtopics.com › view › researchers-announce-positiveResearchers Announce Positive Efficacy Results for Long-Acting...

    8 mag 2024 · Teva and Medincell announce positive phase 3 efficacy results from SOLARIS trial evaluating TEV-‘749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia.